You are using an older browser version. Please use a supported version for the best MSN experience.

Oxford University to Trial New Covid-19 Test for Asymptomatics

Bloomberg logoBloomberg 10/29/2020 Tiago Ramos Alfaro
a person wearing a costume: A lab technician uses a single channel pipette dropper in the immunogenicity testing process during production of the 'Medgamal' COVID-19 vaccine, developed by the Gamaleya National Research Center for Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF), at the Gamaleya National Research Center in Moscow, Russia, on Thursday, Aug. 6, 2020. Some medical staff and city government workers in Moscow are being offered the opportunity to inoculate against the coronavirus as Russia is poised to register what it says is the worlds first Covid-19 vaccine. © Photographer: Bloomberg/Bloomberg A lab technician uses a single channel pipette dropper in the immunogenicity testing process during production of the 'Medgamal' COVID-19 vaccine, developed by the Gamaleya National Research Center for Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF), at the Gamaleya National Research Center in Moscow, Russia, on Thursday, Aug. 6, 2020. Some medical staff and city government workers in Moscow are being offered the opportunity to inoculate against the coronavirus as Russia is poised to register what it says is the worlds first Covid-19 vaccine.

(Bloomberg) -- The University of Oxford will trial a new testing technology that aims to identify asymptomatic individuals with the coronavirus.

Trials of the technology will go ahead over the next few weeks across the U.K., according to an announcement Thursday. It is expected the test will produce results within minutes.

Some staff and students of the university will be offered tests as part of the study and will be trained in how to process and record results using the U.K.’s test-and-trace application.

Oxford, which is also working on a potential vaccine with AstraZeneca Plc, is developing the pilot test program in partnership with the U.K.’s Department of Health, Public Health England and Durham University.

For more articles like this, please visit us at bloomberg.com

©2020 Bloomberg L.P.

AdChoices
AdChoices
AdChoices
image beaconimage beaconimage beacon